[Vaccination strategies against HPV. Recommendations from a European perspective].
Most countries in Western Europe have recommended human papillomavirus (HPV) vaccination for the prevention of cervical cancer. The burden of cervical cancer remains high worldwide with regional differences in incidence rates and mortality. Due to varying conditions in health care systems and nationwide data in the individual European countries, there are slightly different cervical cancer prevention strategies. There is an overall consensus to monitor the public health impact of HPV vaccines. Despite having different prevention strategies and vaccination recommendations in the individual European countries, consideration of how to evaluate and coordinate pan-European surveillance measures should be taken into account.
Deleré
Y
Y
Abt. f. Infektionsepidemiologie, Robert Koch-Institut, Postfach 650261, 13302, Berlin. DelereY@rki.de
D005060:Europe; D005260:Female; D006801:Humans; D032541:Mass Vaccination / Q000592:standards*; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D017410:Practice Guidelines as Topic; D011230:Precancerous Conditions / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*
D053918:Papillomavirus Vaccines